New Jersey’s warning follows a number of steps taken by federal regulators to mitigate the liver risks associated with acetaminophen products. We are pleased that this important public health issue continues to receive the attention it deserves.
New York, New York (PRWEB) February 02, 2015
The Tylenol lawyers (http://www.tylenollawsuitcenter.com/) at Bernstein Liebhard LLP note that a top official with the New Jersey Poison Information and Education System (NJPIES) has warned consumers about the serious risks potentially associated with acetaminophen, the active ingredient in Tylenol-brand over-the-counter medicines. According to the state’s Director of Drug information and Professional Education, taking too much acetaminophen can “literally destroy the liver,” potentially leading to death. The official also warned that some individuals have exceeded the recommended daily dose of acetaminophen by unknowingly taking two or more medications that contained the ingredient. It was also noted that consuming alcohol while taking acetaminophen can also lead to serious liver problems.*
“New Jersey’s warning follows a number of steps taken by federal regulators to mitigate the liver risks associated with acetaminophen products. We are pleased that this important public health issue continues to receive the attention it deserves,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal reviews to consumers who were allegedly harmed by a Tylenol-brand over-the-counter medication.
Tylenol and liver damage
Last year, an investigation published by Consumer Reports revealed that acetaminophen-induced liver damage sends more than 80,000 people to the emergency room every year. Among other things, the report detailed one study which suggested that exceeding just 4,000 milligrams of acetaminophen for just a few days can result in serious liver problems and other complications. Yet the daily limits recommended for many over-the-counter acetaminophen products come very close to this threshold.**
In January 2014, the U.S. Food & Drug Administration (FDA) finalized new guidance for the use of acetaminophen in prescription medications. However, these new guidelines do not apply to over-the-counter medications like Tylenol.*** In October of the same year, the agency issued draft guidance regarding over-the-counter liquid pediatric medications that contain acetaminophen that were also aimed at mitigating the risk of serious liver injury and death.****
According to court documents, at least 163 Tylenol liver damage lawsuits are currently pending in a federal multidistrict litigation underway in the U.S. District Court, Eastern District of Pennsylvania, all of which accuse Johnson & Johnson and McNeil Consumer Healthcare of failing to provide consumers with adequate warnings regarding the risks associated with acetaminophen. Among other things, plaintiffs claim that liver damage caused by Tylenol occurred even though the medication was used in accordance with label directions, and was severe enough to result in hospitalization, liver transplantation, or death. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)
In August 2013, McNeil Consumer Healthcare announced that it would add new, more prominent warnings regarding the risk of liver damage to the labels of Tylenol-brand medications. However, over-the-counter Extra Strength Tylenol caplets each contain 500 mg of acetaminophen, which is higher than the current limits set by the FDA for prescription medications that contain this active ingredient.*****
Individuals who suffered serious liver damage allegedly related to the acetaminophen in a Tylenol medication may be entitled to compensation for their injury-related damages. To learn more about the potential link between Tylenol and liver damage, please visit Bernstein Liebhard LLP's website. Free, confidential and no-obligation case reviews are available by calling 800-511-5092.
*nj1015.com/nj-health-officials-warn-against-acetaminophen/, NJ1015.com, January 28, 2015
**newsnet5.com/money/consumer/consumer-specialist/warning-about-acetaminophen-consumer-reports-investigates, Consumer Reports (via 5 ABC News) October 29, 2014
***latimes.com/science/sciencenow/la-sci-sn-extra-strength-acetaminophen-fda-20140428-story.html, LA Times, April 28, 2014
****fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM417568.pdf, FDA, October 2014
*****bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP